137 related articles for article (PubMed ID: 31186726)
21. [Detection of epidermal growth factor receptor gene mutations in advanced non-small cell lung cancer].
Wang S; Han XH; Li JL; Hu XS; Wang XY; Gui L; Zhao LD; Sun Y; Shi YK
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):530-3. PubMed ID: 23157744
[TBL] [Abstract][Full Text] [Related]
22. Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry.
Kawahara A; Azuma K; Sumi A; Taira T; Nakashima K; Aikawa E; Abe H; Yamaguchi T; Takamori S; Akiba J; Kage M
Lung Cancer; 2011 Oct; 74(1):35-40. PubMed ID: 21444121
[TBL] [Abstract][Full Text] [Related]
23. Simple polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: applications of this method for the diagnosis of non-small-cell lung cancer.
Uhara M; Matsuda K; Taira C; Higuchi Y; Okumura N; Yamauchi K
Clin Chim Acta; 2009 Mar; 401(1-2):68-72. PubMed ID: 19063875
[TBL] [Abstract][Full Text] [Related]
24. Possible False Results With cobas
Kanaoka K; Tamiya A; Inagaki Y; Taniguchi Y; Nakao K; Takeda M; Matsuda Y; Okishio K; Shimizu S
Anticancer Res; 2023 Jun; 43(6):2771-2776. PubMed ID: 37247929
[TBL] [Abstract][Full Text] [Related]
25. Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.
Chen K; Yu X; Wang H; Huang Z; Xu Y; Gong L; Fan Y
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1179-1187. PubMed ID: 29063948
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor exon 20 mutation increased in post-chemotherapy patients with non-small cell lung cancer detected with patients' blood samples.
Wang Y; Bao W; Shi H; Jiang C; Zhang Y
Transl Oncol; 2013 Aug; 6(4):504-10. PubMed ID: 23908693
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.
Riely GJ; Pao W; Pham D; Li AR; Rizvi N; Venkatraman ES; Zakowski MF; Kris MG; Ladanyi M; Miller VA
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):839-44. PubMed ID: 16467097
[TBL] [Abstract][Full Text] [Related]
28. Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.
Rossi S; Toschi L; Finocchiaro G; Di Noia V; Bonomi M; Cerchiaro E; Ceresoli GL; Beretta GD; D'Argento E; Santoro A
Clin Lung Cancer; 2019 Mar; 20(2):82-87. PubMed ID: 30473385
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of acquired resistance-related molecules in Japanese patients with NSCLC treated with an EGFR-TKI.
Uramoto H; Yamada T; Yano S; Kondo N; Hasegawa S; Tanaka F
Anticancer Res; 2012 Sep; 32(9):3785-90. PubMed ID: 22993320
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].
Dong QG; Han BH; Huang JS; Yang LM; Huang J; Zhao CY; Lu LQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):686-90. PubMed ID: 17274376
[TBL] [Abstract][Full Text] [Related]
31. Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
Jackman DM; Yeap BY; Sequist LV; Lindeman N; Holmes AJ; Joshi VA; Bell DW; Huberman MS; Halmos B; Rabin MS; Haber DA; Lynch TJ; Meyerson M; Johnson BE; Jänne PA
Clin Cancer Res; 2006 Jul; 12(13):3908-14. PubMed ID: 16818686
[TBL] [Abstract][Full Text] [Related]
32. Molecular characteristics and clinical outcomes of
Su J; Zhong W; Zhang X; Huang Y; Yan H; Yang J; Dong Z; Xie Z; Zhou Q; Huang X; Lu D; Yan W; Wu YL
Oncotarget; 2017 Dec; 8(67):111246-111257. PubMed ID: 29340050
[TBL] [Abstract][Full Text] [Related]
33. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
Han JY; Kim SH; Lee YS; Lee SY; Hwang JA; Kim JY; Yoon SJ; Lee GK
Lung Cancer; 2014 Aug; 85(2):161-7. PubMed ID: 24857785
[TBL] [Abstract][Full Text] [Related]
34. Correlation between EGFR Gene Mutations and Lung Cancer: a Hospital-Based Study.
Matam K; Goud I; Lakshmi M AM; Ravi V; Sridhar K; Vijayanand PR; Chakravarthy S; Prasad SV; Tabassum SN; Shaik NA; Syed R; Alharbi KK; Khan IA
Asian Pac J Cancer Prev; 2015; 16(16):7071-6. PubMed ID: 26514492
[TBL] [Abstract][Full Text] [Related]
35. Highly Sensitive and Reliable Detection of EGFR Exon 19 Deletions by Droplet Digital Polymerase Chain Reaction.
Oskina N; Oscorbin I; Khrapov E; Boyarskikh U; Subbotin D; Demidova I; Imyanitov E; Filipenko M
Mol Diagn Ther; 2017 Oct; 21(5):555-562. PubMed ID: 28589341
[TBL] [Abstract][Full Text] [Related]
36. Postoperative survival of EGFR-TKI-targeted therapy in non-small cell lung cancer patients with EGFR 19 or 21 mutations: a retrospective study.
Yang W; Gao Y; Li X; Zhang J; Liu T; Feng X; Pan H; Yang X; Xie S; Feng X; Lv Z; Wang Y; Chen Z; He J
World J Surg Oncol; 2017 Nov; 15(1):197. PubMed ID: 29110716
[TBL] [Abstract][Full Text] [Related]
37. Cross-Platform Comparison of Four Leading Technologies for Detecting
Xu T; Kang X; You X; Dai L; Tian D; Yan W; Yang Y; Xiong H; Liang Z; Zhao GQ; Lin S; Chen KN; Xu G
Theranostics; 2017; 7(6):1437-1446. PubMed ID: 28529628
[TBL] [Abstract][Full Text] [Related]
38. EGFR and erbB2 mutation status in Japanese lung cancer patients.
Sasaki H; Shimizu S; Endo K; Takada M; Kawahara M; Tanaka H; Matsumura A; Iuchi K; Haneda H; Suzuki E; Kobayashi Y; Yano M; Fujii Y
Int J Cancer; 2006 Jan; 118(1):180-4. PubMed ID: 16003726
[TBL] [Abstract][Full Text] [Related]
39. Differences in epidermal growth factor receptor gene mutations and relationship with clinicopathological features in NSCLC between Uygur and Han ethnic groups.
Zhang Y; Wang Q; Han ZG; Shan L
Asian Pac J Cancer Prev; 2013; 14(5):2879-83. PubMed ID: 23803047
[TBL] [Abstract][Full Text] [Related]
40. [The research status and development trend of EGFR gene exon 20 insertion mutant non-small cell lung cancer].
Yang GJ; Wang Y
Zhonghua Zhong Liu Za Zhi; 2020 Jan; 42(1):22-29. PubMed ID: 32023765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
